Immunoliposomes as an emerging nanocarrier for breast cancer therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunoliposomes as an emerging nanocarrier for breast cancer therapy
Authors
Keywords
-
Journal
EUROPEAN POLYMER JOURNAL
Volume 184, Issue -, Pages 111781
Publisher
Elsevier BV
Online
2022-12-19
DOI
10.1016/j.eurpolymj.2022.111781
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer
- (2022) Afsana Sheikh et al. Frontiers in Pharmacology
- Emerging innovations in cold plasma therapy against cancer: A paradigm shift
- (2022) Sunil Kumar Dubey et al. DRUG DISCOVERY TODAY
- Folic acid conjugated poly(amidoamine) dendrimer as a smart nanocarriers for tracing, imaging, and treating cancers over-expressing folate receptors
- (2022) Mahak Fatima et al. EUROPEAN POLYMER JOURNAL
- Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics
- (2022) Afsana Sheikh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Dendrimer as a momentous tool in tissue engineering and regenerative medicine
- (2022) Aazam Shaikh et al. JOURNAL OF CONTROLLED RELEASE
- Tetracycline Encapsulated in Au Nanoparticle-Decorated ZnO Nanohybrids for Enhanced Antibacterial Activity
- (2022) Saleh A. Ahmed et al. ACS Applied Nano Materials
- Polymeric nanoparticles-siRNA as an emerging nano-polyplexes against ovarian cancer
- (2022) Urushi Rehman et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Recent advances in nanogold as a promising nanocarrier for curcumin delivery
- (2022) Ali Mahmoudi et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Exploring dendrimer-based drug delivery systems and their potential applications in cancer immunotherapy
- (2022) Shreyas Mukherjee et al. EUROPEAN POLYMER JOURNAL
- Recent advances in multifunctional dendrimer-based nanoprobes for breast cancer theranostics
- (2022) Prashant Kesharwani et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- An insight on topically applied formulations for management of various skin disorders
- (2022) Amit K. Jain et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Recent trends in the application of nanoparticles in cancer therapy: The involvement of oxidative stress
- (2022) Mehdi Sanati et al. JOURNAL OF CONTROLLED RELEASE
- Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment
- (2022) Vanshikha Singh et al. Biosensors-Basel
- Precision medicine: Ray of hope in overcoming cancer multidrug resistance
- (2022) Pankaj Musyuni et al. DRUG RESISTANCE UPDATES
- QbD Enabled Azacitidine Loaded Liposomal Nanoformulation and Its In Vitro Evaluation
- (2021) Prashant Kesharwani et al. Polymers
- The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
- (2021) Sima Singh et al. DRUG DISCOVERY TODAY
- Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer
- (2021) Sunil Kumar Dubey et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer
- (2021) Rahul Chadar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Surface engineered nanocarriers for the management of breast cancer
- (2021) Yanamandala Nitheesh et al. Materials Science & Engineering C-Materials for Biological Applications
- Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer
- (2021) Afsana Sheikh et al. BIOMEDICINE & PHARMACOTHERAPY
- Taxanes loaded polymersomes as an emerging polymeric nanocarrier for cancer therapy
- (2021) Vanshikha Singh et al. EUROPEAN POLYMER JOURNAL
- Chitosan: A versatile bio-platform for breast cancer theranostics
- (2021) Vijay Sagar Madamsetty et al. JOURNAL OF CONTROLLED RELEASE
- Bio‐Conjugated Advanced Materials for Targeted Disease Theranostics
- (2020) Xi‐Le Hu et al. ADVANCED FUNCTIONAL MATERIALS
- Prototyping Trastuzumab Docetaxel Immunoliposomes with a New FCM-Based Method to Quantify Optimal Antibody Density on Nanoparticles
- (2020) A. Rodallec et al. Scientific Reports
- Synthesis, characterization and in vitro assessment of colloidal gold nanoparticles of Gemcitabine with natural polysaccharides for treatment of breast cancer
- (2020) Laxmi Devi et al. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
- Formulation and Development of Transferrin Targeted Solid Lipid Nanoparticles for Breast Cancer Therapy
- (2020) Geeta S. Bhagwat et al. Frontiers in Pharmacology
- Nano-MOFs as targeted drug delivery agents to combat antibiotic-resistant bacterial infections
- (2020) Saleh A. Ahmed et al. Royal Society Open Science
- Multicomponent Access to novel Proline/Cyclized Cysteine Tethered Monastrol Conjugates as Potential Anticancer Agents
- (2019) M. Shaheer Malik et al. Journal of Saudi Chemical Society
- EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers
- (2019) Lucyna Matusewicz et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Tumor uptake and associated greater efficacy of anti-Her2 immunoliposome does not rely on Her2 expression status
- (2019) Anne Rodallec et al. ANTI-CANCER DRUGS
- Photo-triggered destabilization of nanoscopic vehicles by dihydroindolizine for enhanced anticancer drug delivery in cervical carcinoma
- (2018) Priya Singh et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
- (2018) Anne Rodallec et al. International Journal of Nanomedicine
- Development and Evaluation of Tri-Functional Immunoliposomes for the Treatment of HER2 Positive Breast Cancer
- (2018) Tanaya Vaidya et al. PHARMACEUTICAL RESEARCH
- Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2—An In Vitro Study
- (2018) Lucyna Matusewicz et al. Cancers
- ‘Nano–in–nano’ hybrid liposomes increase target specificity and gene silencing efficiency in breast cancer induced SCID mice
- (2017) Dhiraj Bhavsar et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy
- (2017) Josimar O. Eloy et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Targeted multidrug delivery system to overcome chemoresistance in breast cancer
- (2017) Yuan Tang et al. International Journal of Nanomedicine
- Construction and evaluation of pH-sensitive immunoliposomes for enhanced delivery of anticancer drug to ErbB2 over-expressing breast cancer cells
- (2017) Tianshu Li et al. Nanomedicine-Nanotechnology Biology and Medicine
- The Cellular Origin and Evolution of Breast Cancer
- (2017) Mei Zhang et al. Cold Spring Harbor Perspectives in Medicine
- Nanotechnology inspired tools for mitochondrial dysfunction related diseases
- (2016) Ru Wen et al. ADVANCED DRUG DELIVERY REVIEWS
- Rapamycin-loaded immunoliposomes functionalized with trastuzumab: a strategy to enhance cytotoxicity to HER2-positive breast cancer cells
- (2016) Josimar Eloy et al. Anti-Cancer Agents in Medicinal Chemistry
- Herceptin-conjugated temperature-sensitive immunoliposomes encapsulating gemcitabine for breast cancer
- (2016) Dae Hwan Shin et al. ARCHIVES OF PHARMACAL RESEARCH
- Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells
- (2015) Yanuar Dwi Putra Limasale et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Radiotherapy effects on early breast cancer survival in observational and randomized studies: a systematic analysis of advantages, disadvantages and differences between the two study types
- (2015) Jochem König et al. Breast Cancer
- Antibody-modified lipid nanoparticles for selective delivery of siRNA to tumors expressing membrane-anchored form of HB-EGF
- (2014) Ayaka Okamoto et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Breast cancer risk reduction - is it feasible to initiate a randomised controlled trial of a lifestyle intervention programme (ActWell) within a national breast screening programme?
- (2014) Annie S Anderson et al. International Journal of Behavioral Nutrition and Physical Activity
- Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells
- (2013) Angela Catania et al. BREAST CANCER RESEARCH AND TREATMENT
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Efficacy of edelfosine lipid nanoparticles in breast cancer cells
- (2013) María Ángela Aznar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Preclinical Evaluation of Genexol-PM, a Nanoparticle Formulation of Paclitaxel, as a Novel Radiosensitizer for the Treatment of Non-Small Cell Lung Cancer
- (2013) Michael E. Werner et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Current trends in the use of liposomes for tumor targeting
- (2013) Pranali P Deshpande et al. Nanomedicine
- Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery
- (2012) Julien Nicolas et al. CHEMICAL SOCIETY REVIEWS
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Targeting Her-2+ Breast Cancer Cells with Bleomycin Immunoliposomes Linked to LLO
- (2012) Max Kullberg et al. MOLECULAR PHARMACEUTICS
- The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes
- (2011) Jie Gao et al. BIOMATERIALS
- Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer
- (2011) Kaoru Nishikawa et al. JOURNAL OF CONTROLLED RELEASE
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
- (2010) Gemma Molyneux et al. Cell Stem Cell
- Trastuzumab
- (2010) Karly P. Garnock-Jones et al. DRUGS
- To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
- (2010) Fabienne Danhier et al. JOURNAL OF CONTROLLED RELEASE
- Cancer stem cells at the crossroads of current cancer therapy failures—Radiation oncology perspective
- (2010) Ulrike Koch et al. SEMINARS IN CANCER BIOLOGY
- Preinvasive Breast Cancer
- (2009) Dennis C. Sgroi Annual Review of Pathology-Mechanisms of Disease
- Nanotechnology for breast cancer therapy
- (2008) Takemi Tanaka et al. BIOMEDICAL MICRODEVICES
- Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes
- (2008) Toyone Kikumori et al. BREAST CANCER RESEARCH AND TREATMENT
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started